This research aims to determine the relationship between hormone therapy and the development of Fuchs endothelial corneal dystrophy.
Conducted a post hoc secondary analysis of the Women’s Health Initiative study.
Assessed randomized hormone therapy use among participants.
Evaluated subsequent incidents of Fuchs endothelial corneal dystrophy.
Findings indicate an association between hormone therapy use and the incidence of Fuchs endothelial corneal dystrophy.
The analysis highlights trends in corneal disease development in women undergoing hormone treatment.
Abstract
This post hoc secondary analysis of the Women’s Health Initiative study assesses whether randomization to hormone therapy use was associated with subsequent incident Fuchs endothelial corneal dystrophy.